Rapport Therapeutics
Jeffrey Sevigny is an accomplished medical professional with extensive experience in neurology and pharmaceutical leadership. Currently serving as the Chief Medical Officer at Rapport Therapeutics since March 2025, Jeffrey previously held the same position at Prevail Therapeutics from March 2018 to January 2025. Additional roles include Board Member at Acumen Pharmaceuticals, Vice President and Global Head of Translational Medicine Neuroscience and Biomarkers at Roche, and Senior Medical Director for Neurodegenerative Disorders at Biogen. Jeffrey's academic background comprises an M.D. from Tufts University School of Medicine and a Master's degree from Columbia University Mailman School of Public Health, along with an A.B. in Biochemistry and Philosophy from Bowdoin College.
This person is not in any teams
This person is not in any offices
Rapport Therapeutics
1 followers
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.